129 related articles for article (PubMed ID: 36081281)
21. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte-to-C-Reactive Protein Ratio as a Novel Marker for Predicting Oncological Outcomes in Patients with Esophageal Cancer.
Takeuchi M; Kawakubo H; Hoshino S; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
World J Surg; 2021 Nov; 45(11):3370-3377. PubMed ID: 34383091
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Xie HL; Liu T; Song MM; Ge YZ; Deng L; Shi HP
Sci Rep; 2023 May; 13(1):7217. PubMed ID: 37137949
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.
Iseda N; Itoh S; Yoshizumi T; Tomiyama T; Morinaga A; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oda Y; Mori M
Int J Clin Oncol; 2021 Oct; 26(10):1890-1900. PubMed ID: 34251555
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of preoperative lymphocyte/C-reactive protein associated with upper gastrointestinal cancer: a meta-analysis.
Ye Y; Wu G; Yuan H; Zheng Y; Wang Y; Guo Q
Front Oncol; 2023; 13():1181649. PubMed ID: 37849797
[TBL] [Abstract][Full Text] [Related]
26. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients.
Yasui K; Shida D; Nakamura Y; Ahiko Y; Tsukamoto S; Kanemitsu Y
Br J Cancer; 2021 Mar; 124(5):933-941. PubMed ID: 33257844
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.
Nishi M; Shimada M; Tokunaga T; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Wada Y; Eto S; Yoshimoto T
World J Surg Oncol; 2021 Jul; 19(1):201. PubMed ID: 34229704
[TBL] [Abstract][Full Text] [Related]
29. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
31. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
[TBL] [Abstract][Full Text] [Related]
33. Postoperative Serum C-Reactive Protein Level Predicts Long-term Outcomes in Stage I Gastric Cancer.
Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
J Surg Res; 2019 Oct; 242():323-331. PubMed ID: 31129241
[TBL] [Abstract][Full Text] [Related]
34. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
[TBL] [Abstract][Full Text] [Related]
35. Impact of geriatric nutritional risk index on outcomes after gastrectomy in elderly patients with gastric cancer: a retrospective multicenter study in Japan.
Matsunaga T; Saito H; Osaki T; Takahashi S; Iwamoto A; Fukuda K; Taniguchi K; Kuroda H; Takeuchi T; Sugamura K; Sumi K; Katano K; Shishido Y; Miyatani K; Fujiwara Y
BMC Cancer; 2022 May; 22(1):540. PubMed ID: 35549906
[TBL] [Abstract][Full Text] [Related]
36. Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer.
Yao WY; Wu XS; Liu SL; Wu ZY; Dong P; Gong W
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):267-272. PubMed ID: 34507896
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Impact of Lymphocyte-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.
Yugawa K; Maeda T; Kinjo N; Kawata K; Ikeda S; Edahiro K; Edagawa M; Omine T; Kometani T; Yamaguchi S; Konishi K; Tsutsui S; Matsuda H
J Gastrointest Surg; 2022 Jan; 26(1):104-112. PubMed ID: 34258673
[TBL] [Abstract][Full Text] [Related]
38. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit.
Lu J; Xu BB; Xue Z; Xie JW; Zheng CH; Huang CM; Li P
Cancer Med; 2021 Jan; 10(1):34-44. PubMed ID: 33270989
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive comparative analysis of the prognostic impact of systemic inflammation biomarkers for patients underwent cardiac surgery.
Liu Z; Zhu G; Zhang Y; Zhang P; Zang W; Shen Z
Front Immunol; 2023; 14():1190380. PubMed ID: 37646036
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]